Oncology Highlights - August 2019
Selection of TP53 missense mutation driven by a dominant-negative effect, neutral genetic drift as cause of long-term cancer evolution, infusions of humanized anti-CD19 and anti-BCMA CAR T cells are feasible
Oncology Highlights - July 2019
Soft drinks and fruit juice associated with increased risk of cancer, enhanced CAR-T cell efficacy in solid tumors, Prolonged PFS in solid tumors with NEO-PV-01
Oncology Highlights - June 2019
Astrocytes play role immunosuppression, TILs related to spatial distribution, FDA and EMA approvals, ASCO guidelines
Oncology Highlights - May 2019
CRISPR FIH trial, Neo-neurogenesis in prostate cancer, CTC prospecting with HydroSeq (scRNA-seq), Industry updates, EMA and FDA approvals in May
Oncology Highlights - April 2019
TAMs' role in cancer, zebrafish model for drug selection, M&A in April, EMA and FDA approvals in April
Oncology Highlights - March 2019
Brain-on-a-chip, upcoming CAR-T therapies, Flagship Pioneering, Tecentriq approval for SCLC and TNBC
Oncology Highlights - February 2019
The Human Tumor Atlas Network (HTAN), barcoding single cells, FDA&EMA approvals, M&A oncology in February
Oncology Highlights - January 2019
Overriding the "don't eat me" signal, AI test predicts aggresive cancer, Lilly buys Loxo, FDA, EMA approvals and more
Oncology Highlights - December 2018
2018 year in review, mining the gold-DNA interactions, skin cells armored to fight cancer, IO market news, FDA's real world evidence program
Oncology Highlights - November 2018
Bacterial "robot-factoriees", fat fueled attenuation of NK cells, 2018 ESMO IO awards, FDA and EMA approvals and more...
Oncology Highlights - October 2018
Markers that reveal resistance to IO, a novel way to block TGF-B, M&A in oncology, Galien awards and more
Oncology Highlights - September 2018
Nobel prize in medicine goes for cancer immunotherapy, linking sugar to cancer, Roche acquires Tusk, FDA guidelines on adaptive trials and more
Oncology Highlights - August 2018
Future is now: digital diagnostic apps, artificial intelligence to predict responders. PD-L1 exosomes, M&A news in oncology
Oncology Highlights - July 2018
Mistimed meals and increased risk of cancer, how reward mechanism boosts immunity, rapid gene editing, European VC climb, IO/IO combination approvals
Oncology Highlights - June 2018
Novel ACT therapy, Vitamin D and lowered cancer risk, iTeos secures $75M, EMA guidance on Brexit
Oncology Highlights - May 2018
Achilles heel in drug-resistant cancer, smart Nanobombs, Lilly's IO spree, Xenikos secure Series B funding..
Oncology Highlights - April 2018
Organoid cultures, NGS in clinical trials, latest Onco M&A and more..
Oncology Highlights - March 2018
ctDNA as liquid biopsy, PET scan for PD-L1 and recent analysis in the European cancer death rate..
Oncology Highlights - February 2018
IO clinical trial landscape, IPSCs as cancer vaccines, DNA origami robots..
Oncology Highlights - January 2018
World Cancer Day, SEEK test, CRISPR trials, M&A peak in 2018..